Skye Bioscience, Inc.
OTC:SKYE
1.74 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||
| Net Income
| -26.567 | -37.645 | -19.482 | -8.522 | -6.561 | 1.052 | -19.194 | -3.094 | -3.178 | -4.841 | -2.734 | -0.12 | 0.005 |
| Depreciation & Amortization
| 0.299 | 0.124 | 0.115 | 0.034 | 0.002 | 0.001 | 0.002 | 0.008 | 0.015 | 0.01 | 0.002 | 0.011 | 0 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | -8.687 | 0 | 0 | -1.235 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 8.317 | 0.988 | 0.629 | 0.869 | 0.303 | 0.68 | 0.675 | 0.609 | 0.706 | 0.414 | 0.011 | 0 | 0 |
| Change In Working Capital
| -2.629 | -0.469 | -0.762 | 0.647 | 0.094 | 0.296 | 0.1 | -0.324 | 0.041 | -0.419 | 0.5 | 0.12 | -0.003 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.007 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -0.587 | -0.701 | 0.8 | 0.519 | 0.242 | 0.134 | -0.085 | -0.174 | 0.149 | -0.274 | 0.407 | 0 | 0 |
| Other Working Capital
| -2.042 | 0.232 | -1.562 | 0.128 | -0.147 | 0.162 | 0.186 | -0.15 | -0.109 | -0.144 | 0.093 | 0.12 | 0.004 |
| Other Non Cash Items
| -4.658 | 23.05 | 6.755 | 0.497 | 0.108 | 0.629 | 14.475 | -0.497 | 0.099 | 1.107 | 0.466 | -0.025 | 0 |
| Operating Cash Flow
| -25.237 | -13.952 | -12.744 | -6.475 | -6.054 | -6.028 | -3.943 | -3.298 | -3.553 | -3.728 | -1.755 | -0.014 | 0.002 |
| Investing Activities: | |||||||||||||
| Investments In Property Plant And Equipment
| -1.604 | -0.013 | -0.028 | -0.091 | -0.007 | 0 | -0.004 | -0.02 | -0.011 | -0.002 | -0.023 | -0.049 | 0 |
| Acquisitions Net
| 0 | 1.077 | 5.309 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 1.358 | 5.532 | -0.066 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.011 | 0 |
| Investing Cash Flow
| -0.246 | 6.596 | 5.214 | -0.091 | -0.007 | 0 | -0.004 | -0.02 | -0.011 | -0.002 | -0.023 | -0.038 | 0 |
| Financing Activities: | |||||||||||||
| Debt Repayment
| 0 | 4.714 | -0.211 | 0 | 0.567 | 0.005 | 2.346 | 0.5 | 0 | 0 | 0 | 0 | 0.002 |
| Common Stock Issued
| 83.557 | 11.735 | 0.002 | 6.063 | 6.086 | 1.919 | 3.096 | 0.188 | 0.05 | 0.721 | 1.986 | 0.049 | 0.008 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.006 | -0.006 | 0.002 | 7.017 | 0.049 | 4.08 | 0.099 | 3.013 | 0.408 | 6.023 | 0 | 0.078 | 0 |
| Financing Cash Flow
| 83.562 | 16.443 | -0.209 | 13.079 | 6.701 | 6.005 | 5.541 | 3.513 | 0.408 | 6.744 | 1.986 | 0.078 | 0.011 |
| Other Information: | |||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 58.079 | 9.088 | -7.738 | 6.514 | 0.639 | -0.023 | 1.594 | 0.195 | -3.156 | 3.014 | 0.207 | 0.026 | 0.012 |
| Cash At End Of Period
| 68.416 | 10.337 | 1.249 | 8.988 | 2.474 | 1.835 | 1.858 | 0.26 | 0.065 | 3.221 | 0.207 | 0.052 | 0.026 |